Dr. Shai Shimony is a leukemia specialist with advanced training from Dana-Farber Cancer Institute and a Master’s in Clinical Effectiveness from Harvard. His clinical and research focus centers around improving care and outcomes for patients with acute leukemias, especially AML, ALL, and rare subtypes like BPDCN.